Skip to main content
. 2013 Apr 1;3(2):e25102. doi: 10.4161/biom.25102

Table 3. A. Design matrix evaluation for response surface quadratic model of non-PEGylated nanoparticles bearing temozolomide.

Table 3A
Degrees of freedom for evaluation
Model
14
Residuals
67
Lack of Fit
66
Pure Error
1
Corr Total 81
Table 3B
           
Term Standard Error** VIF Ri-squared Power at 5% α level for effect of
0.5 Std. Dev. 1 Std. Dev. 2 Std. Dev.
A
0.136083
1
0
44.10%
95.20%
99.90%
B
0.136083
1
0
44.10%
95.20%
99.90%
C
0.136083
1
0
44.10%
95.20%
99.90%
D
0.136083
1
0
44.10%
95.20%
99.90%
AB
0.166667
1
0
31.50%
84.10%
99.90%
AC
0.166667
1
0
31.50%
84.10%
99.90%
AD
0.166667
1
0
31.50%
84.10%
99.90%
BC
0.166667
1
0
31.50%
84.10%
99.90%
BD
0.166667
1
0
31.50%
84.10%
99.90%
CD
0.166667
1
0
31.50%
84.10%
99.90%
A^2
0.233069
1.001626
0.0016234
56.10%
98.80%
99.90%
B^2
0.233069
1.001626
0.0016234
56.10%
98.80%
99.90%
C^2
0.233069
1.001626
0.0016234
56.10%
98.80%
99.90%
D^2 0.233069 1.001626 0.0016234 56.10% 98.80% 99.90%
**

Basis s.d = 1.0.